530697 Stock Overview
Engages in the marketing and distribution of pharmaceutical products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Zenlabs Ethica Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹40.80 |
| 52 Week High | ₹70.00 |
| 52 Week Low | ₹36.00 |
| Beta | -0.70 |
| 11 Month Change | -2.35% |
| 3 Month Change | -0.24% |
| 1 Year Change | -8.25% |
| 33 Year Change | 24.77% |
| 5 Year Change | -10.62% |
| Change since IPO | 2,756.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530697 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 2.1% | 0.8% | 0.3% |
| 1Y | -8.3% | 36.4% | 27.3% |
Return vs Industry: 530697 underperformed the Indian Healthcare industry which returned 36.4% over the past year.
Return vs Market: 530697 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 530697 volatility | |
|---|---|
| 530697 Average Weekly Movement | 9.3% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 530697's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 530697's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 65 | Sanjeev Singal | www.zenlabsethica.com |
Zenlabs Ethica Limited engages in the marketing and distribution of pharmaceutical products in India. It markets analgesics and anti-inflammatory drugs; skin preparations; drugs for neurological and GIT disorders; ear, eye, and nasal drops; anti-diabetic, anti-depressant, anti-infective, anti-emetic, anti-hypertensive, anti-allergic, and anti-cold and cough syrups; steroids and anabolic steroids; nutraceuticals; antacids, enzymes, and appetite stimulants; ayurvedic preparations; soaps; dusting powders; soaps; and other pharmaceutical drugs. The company is also involved in the private label manufacturing of various pharmaceutical products, such as tablets, capsules, injections, syrups, and ointments; and therapeutics, such as anti-infective, anti-obesity, anti-bacterial, anti-hypertensives, anti-fungal, pain killers, and nutritional supplements.
Zenlabs Ethica Limited Fundamentals Summary
| 530697 fundamental statistics | |
|---|---|
| Market cap | ₹262.35m |
| Earnings (TTM) | ₹3.60m |
| Revenue (TTM) | ₹566.41m |
73.7x
P/E Ratio0.5x
P/S RatioIs 530697 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530697 income statement (TTM) | |
|---|---|
| Revenue | ₹566.41m |
| Cost of Revenue | ₹419.14m |
| Gross Profit | ₹147.27m |
| Other Expenses | ₹143.67m |
| Earnings | ₹3.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.55 |
| Gross Margin | 26.00% |
| Net Profit Margin | 0.64% |
| Debt/Equity Ratio | 97.4% |
How did 530697 perform over the long term?
See historical performance and comparison